Market Cap 1.59B
Revenue (ttm) 5.78B
Net Income (ttm) 86.00M
EPS (ttm) N/A
PE Ratio 10.52
Forward PE 7.00
Profit Margin 1.49%
Debt to Equity Ratio 7.08
Volume 4,153,300
Avg Vol 3,659,128
Day's Range N/A - N/A
Shares Out 149.67M
Stochastic %K 53%
Beta 1.65
Analysts Sell
Price Target $14.70

Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offe...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 302 773 1000
Address:
1007 Market Street, P.O. Box 2047, Wilmington, United States
windough
windough Jun. 23 at 6:00 PM
$CC i paid 1030
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 4:11 PM
$CC riding Opteon momentum — here’s why it matters for Q2 📈 Second-quarter sales are projected to hit the high end of guidance, with strong Opteon demand helping counter Thermal & Specialized Solutions disruptions. Full Q2 setup here 👉 https://www.zacks.com/stock/news/2534998/cc-sees-gains-from-opteon-growth-in-q2-navigates-disruptions-in-tt?cid=sm-stocktwits-2-2534998-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2534998_TEASER
0 · Reply
Cliffynet
Cliffynet Jun. 23 at 2:39 PM
$CC this is one of the Best buy and Short stocks.. easily earn a 3-5% per week
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 12:32 PM
$CC down 51.5% over the past year — is it time to sell? 📉 Despite expecting high-end Q2 sales, CC faces a Zacks Rank #5 (Strong Sell) amid operational disruptions and increased corporate costs. See the full breakdown here 👉 https://www.zacks.com/commentary/2534998/cc-sees-gains-from-opteon-growth-in-q2-navigates-disruptions-in-tt?cid=sm-stocktwits-2-2534998-body&ADID=SYND_STOCKTWITS_TWEET_2_2534998_BODY
0 · Reply
Cliffynet
Cliffynet Jun. 20 at 6:06 PM
$CC hopeless!!
0 · Reply
Cliffynet
Cliffynet Jun. 18 at 3:10 PM
$CC are we out of the woods? .. hmm
0 · Reply
DonCorleone77
DonCorleone77 Jun. 18 at 11:01 AM
$CC Chemours sees Q2 adjusted EBITDA $215M-$225M The Chemours Company, a global chemistry company with leading market positions in Thermal & Specialized Solutions, or TSS, Titanium Technologies, or TT, and Advanced Performance Materials, or APM, provided an update on its Q2 outlook. For the Q2, due to better-than-expected performance, TSS now anticipates a sequential increase in Net Sales of approximately 25% driven by strong demand for Opteon Refrigerants, in connection with the stationary transition to low global warming potential refrigerants under the U.S. AIM Act. Consistent with this increased demand, TSS also projects a sequential increase in Adjusted EBITDA of nearly 40% for the quarter. APM's Adjusted EBITDA for the Q2 is also anticipated to increase nearly 25% sequentially due to stronger overall cost performance, while Net Sales are anticipated to be within original expectations of low teens sequential growth. For TT, the Company anticipates overall Net Sales for the Q2 to be in line with the segment's high single-digit growth expectations. However, Q2 Adjusted EBITDA for TT is now projected to decline approximately 15% sequentially, due to operational disruptions at its U.S. sites. These disruptions were primarily caused by a rail line service interruption impacting feedstock mix and other limited operational issues. In order to fulfill customer orders due to the rail line disruption, the Company elected to consume higher-cost ore feedstock, which resulted in incremental costs of approximately $15M in the Q2. The costs associated with other one-time operational disruptions are expected to be approximately $10M for the quarter. As a part of the Company's strategic focus to resolve legacy litigation, under the Strengthening the Long Term pillar, the Company now anticipates overall corporate costs for the Q2 to be slightly higher-than-expected in connection with the ongoing New Jersey trial. Overall, consolidated Net Sales for the Q2 are expected to be at the high end of the original range, now anticipating a sequential mid-teens increase. Consolidated Adjusted EBITDA is now projected to range between $215M-$225M, with consolidated Free Cash Flow projected to remain positive in the Q2.
1 · Reply
Cliffynet
Cliffynet Jun. 16 at 7:05 PM
$CC so screwed .. cc can’t even stand still but back track. No one wants this shit! Darn it
0 · Reply
prstrader
prstrader Jun. 16 at 4:48 PM
$AAL $AAPL $CC “US cancels new round of talks with Russia, — Russian MFA Moscow does not know whether these talks will take place at all.”
0 · Reply
Cliffynet
Cliffynet Jun. 13 at 4:48 PM
$CC coming to 10% in 2 days??! What a joke!
0 · Reply
Latest News on CC
Chemours Guides for 2Q Sales at High End of Prior Forecast

Jun 18, 2025, 7:10 AM EDT - 6 days ago

Chemours Guides for 2Q Sales at High End of Prior Forecast


The Chemours Company (CC) Q1 2025 Earnings Call Transcript

May 7, 2025, 2:05 PM EDT - 6 weeks ago

The Chemours Company (CC) Q1 2025 Earnings Call Transcript


Chemours: Dividend Cut May Signal A Bottom Is Near

May 6, 2025, 11:41 PM EDT - 7 weeks ago

Chemours: Dividend Cut May Signal A Bottom Is Near


The Chemours Company Reports First Quarter 2025 Results

May 6, 2025, 4:30 PM EDT - 7 weeks ago

The Chemours Company Reports First Quarter 2025 Results


The Long-Term Upside For Chemours Company After Q4 2024

Feb 19, 2025, 7:01 AM EST - 4 months ago

The Long-Term Upside For Chemours Company After Q4 2024


The Chemours Company (CC) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 11:06 AM EST - 4 months ago

The Chemours Company (CC) Q4 2024 Earnings Call Transcript


Chemours Announces First Quarter Dividend

Feb 14, 2025, 4:30 PM EST - 4 months ago

Chemours Announces First Quarter Dividend


Chemours Appoints Leslie M. Turner to its Board of Directors

Feb 11, 2025, 4:30 PM EST - 4 months ago

Chemours Appoints Leslie M. Turner to its Board of Directors


The Chemours Company (CC) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 11:25 AM EST - 8 months ago

The Chemours Company (CC) Q3 2024 Earnings Call Transcript


Chemours Announces Fourth Quarter Dividend

Oct 23, 2024, 4:15 PM EDT - 8 months ago

Chemours Announces Fourth Quarter Dividend


Top 7 Tax-Loss Stocks To Sell By October 31, 2024

Oct 21, 2024, 8:25 AM EDT - 8 months ago

Top 7 Tax-Loss Stocks To Sell By October 31, 2024

APO CELH CLF DG DLTR FIVE


windough
windough Jun. 23 at 6:00 PM
$CC i paid 1030
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 4:11 PM
$CC riding Opteon momentum — here’s why it matters for Q2 📈 Second-quarter sales are projected to hit the high end of guidance, with strong Opteon demand helping counter Thermal & Specialized Solutions disruptions. Full Q2 setup here 👉 https://www.zacks.com/stock/news/2534998/cc-sees-gains-from-opteon-growth-in-q2-navigates-disruptions-in-tt?cid=sm-stocktwits-2-2534998-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2534998_TEASER
0 · Reply
Cliffynet
Cliffynet Jun. 23 at 2:39 PM
$CC this is one of the Best buy and Short stocks.. easily earn a 3-5% per week
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 12:32 PM
$CC down 51.5% over the past year — is it time to sell? 📉 Despite expecting high-end Q2 sales, CC faces a Zacks Rank #5 (Strong Sell) amid operational disruptions and increased corporate costs. See the full breakdown here 👉 https://www.zacks.com/commentary/2534998/cc-sees-gains-from-opteon-growth-in-q2-navigates-disruptions-in-tt?cid=sm-stocktwits-2-2534998-body&ADID=SYND_STOCKTWITS_TWEET_2_2534998_BODY
0 · Reply
Cliffynet
Cliffynet Jun. 20 at 6:06 PM
$CC hopeless!!
0 · Reply
Cliffynet
Cliffynet Jun. 18 at 3:10 PM
$CC are we out of the woods? .. hmm
0 · Reply
DonCorleone77
DonCorleone77 Jun. 18 at 11:01 AM
$CC Chemours sees Q2 adjusted EBITDA $215M-$225M The Chemours Company, a global chemistry company with leading market positions in Thermal & Specialized Solutions, or TSS, Titanium Technologies, or TT, and Advanced Performance Materials, or APM, provided an update on its Q2 outlook. For the Q2, due to better-than-expected performance, TSS now anticipates a sequential increase in Net Sales of approximately 25% driven by strong demand for Opteon Refrigerants, in connection with the stationary transition to low global warming potential refrigerants under the U.S. AIM Act. Consistent with this increased demand, TSS also projects a sequential increase in Adjusted EBITDA of nearly 40% for the quarter. APM's Adjusted EBITDA for the Q2 is also anticipated to increase nearly 25% sequentially due to stronger overall cost performance, while Net Sales are anticipated to be within original expectations of low teens sequential growth. For TT, the Company anticipates overall Net Sales for the Q2 to be in line with the segment's high single-digit growth expectations. However, Q2 Adjusted EBITDA for TT is now projected to decline approximately 15% sequentially, due to operational disruptions at its U.S. sites. These disruptions were primarily caused by a rail line service interruption impacting feedstock mix and other limited operational issues. In order to fulfill customer orders due to the rail line disruption, the Company elected to consume higher-cost ore feedstock, which resulted in incremental costs of approximately $15M in the Q2. The costs associated with other one-time operational disruptions are expected to be approximately $10M for the quarter. As a part of the Company's strategic focus to resolve legacy litigation, under the Strengthening the Long Term pillar, the Company now anticipates overall corporate costs for the Q2 to be slightly higher-than-expected in connection with the ongoing New Jersey trial. Overall, consolidated Net Sales for the Q2 are expected to be at the high end of the original range, now anticipating a sequential mid-teens increase. Consolidated Adjusted EBITDA is now projected to range between $215M-$225M, with consolidated Free Cash Flow projected to remain positive in the Q2.
1 · Reply
Cliffynet
Cliffynet Jun. 16 at 7:05 PM
$CC so screwed .. cc can’t even stand still but back track. No one wants this shit! Darn it
0 · Reply
prstrader
prstrader Jun. 16 at 4:48 PM
$AAL $AAPL $CC “US cancels new round of talks with Russia, — Russian MFA Moscow does not know whether these talks will take place at all.”
0 · Reply
Cliffynet
Cliffynet Jun. 13 at 4:48 PM
$CC coming to 10% in 2 days??! What a joke!
0 · Reply
TwoToesTrading
TwoToesTrading Jun. 12 at 7:53 PM
0 · Reply
dennismccain
dennismccain Jun. 11 at 2:23 PM
I don’t think chemical companies will ever be considered an exciting investment, but they do at times become tradable when they get over bought or oversold. Today $CC appears to be oversold. Now I don’t pretend to know where the bottom will ultimately be established, but $10 is looking like a likely candidate for that honor. On a recent scan of chemical companies, Chemours (best known for creating Teflon) was identified as having the lowest projected forward P/E at just 4.77. Moving that up to just 8 or 10 times projected earnings will get you to a price target somewhere between $20 and $24 per share. That’s basically a double from here. So today I’m picking up a few shares to monitor this stock. Options are weekly so that’s another avenue I’ll obviously pursue in time. All in all this should be quite interesting.
2 · Reply
StockmanJones
StockmanJones Jun. 9 at 2:33 PM
$CC good recovery after ex div date. I’ll Be back in 3 years
0 · Reply
swingingtech
swingingtech Jun. 5 at 5:40 PM
$CC https://wallstreetwaves.com/maximizing-chemours-returns-to-22-8-with-options-strategies/
0 · Reply
BillSeller
BillSeller Jun. 5 at 5:29 PM
$CC fuck, should have waited!
0 · Reply
Merica90
Merica90 Jun. 3 at 3:37 PM
$CC short squeeze?
1 · Reply
Bazzzigar
Bazzzigar Jun. 2 at 10:42 PM
$CC BON
0 · Reply
MattP_
MattP_ Jun. 2 at 6:47 PM
$CC No idea whats up with this lately but I'll buy some more
0 · Reply
Yerff
Yerff Jun. 2 at 6:03 PM
$CC Shorts are very aggressive on this ticker. Industrials sector is red today tho, I'll add a little bit for a quick reversal
0 · Reply
Cliffynet
Cliffynet Jun. 2 at 5:59 PM
$CC 🏦 Institutional Selling Activity • Nuveen Asset Management LLC: Recently sold 57,329 shares of Chemours stock, as reported on June 1, 2025.  • Bank of America Corp DE: Also reported selling shares of Chemours on June 1, 2025.
0 · Reply
LookingForAFish
LookingForAFish Jun. 2 at 5:48 PM
$CC it keeps dropping because they don't make money.
1 · Reply
Cliffynet
Cliffynet Jun. 2 at 5:28 PM
$CC darn all time low!!
0 · Reply